PeptideStack
5.2kquestions
20kanswers
220users

What happens to survodutide after four weeks at 4 °C in solution?

Asked 13 Apr 2026Modified 2 days agoViewed 4.5k times
15

Concretely: survodutide · four weeks · 4 °C.

I want to know whether this is a real physical effect or an artefact of how it is measured.

What prompted the question is an inconsistency between two sources I otherwise trust.

What is the causal chain, and where does it stop being established?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
shareeditfollowflag
RP
askedravi_pillai12k1713 Apr 2026
6Same question here after a warm delivery, so I am following this. – Dr_Rosalind_Achebe 4 months ago
5Worth saying whether the vial has been opened, because that starts a different clock. – Dr_Ravi_Selvarajah 3 months ago
add a comment

4 Answers

Accepted answer first, then by votes
11

Accepted answer

four weeks is 28 days, which at 4 °C is on the order of 26 refrigerated days. 4 °C is the condition the rule of thumb is anchored to, so it is the baseline rather than a multiplier: everything else in this thread is quoted relative to it. In solution the routes that matter are hydrolysis of the backbone, deamidation at Asn, and physical association — the first two cost content, the third costs neither until it precipitates. Over 28 days at 4 °C you should expect all three to have moved, and a purity figure to have noticed only some of them. Reconstituted material has no certificate; the one in the box describes the powder.

The relevant point is that a mass shift of plus one dalton is deamidation and plus sixteen is oxidation, so degradation is often visible in a mass spectrum if anyone looks.

Oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

Adsorption losses at low concentrations are quantified in formulation studies and are the reason carrier proteins are used in dilute preparations.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
FC
answered · acceptedforty_two_c66k5828 Jul 2026
3Worth adding that residual moisture predicts this better than any printed date. – ilaria_bertone 7 months ago
2The doubling-per-ten-degrees rule is the part I did not know and now use constantly. – grainne_ahearn 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
3

Aggregation is a physical process and is the one most often caused by handling rather than by time.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

To be exact about it, light exposure matters for tryptophan-containing sequences and for anything with a chromophore. Amber vials and a closed box are free mitigations.

Deamidation via the succinimide intermediate is well characterised, with sequence-dependent rates highest for asparagine-glycine motifs.

Sequence decides which pathways are even available. Check the residues.

edited 16 Jul 2026 by mala_venkatesh — added the placebo-arm figures

shareimprove this answerflag
MV
answeredmala_venkatesh22k3715 Jul 2026
2

Answering this needs the physical state, since a dry powder is protected from most of these and a solution is protected from none.

Freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Swirl, never shake. Aggregation is a handling problem more than a time problem.

shareimprove this answerflag
TH
answeredthreadlock719k287 May 2026
6Thank you — this is the answer I was looking for. – tandem_gradient 9 months ago
5Is there a reason to prefer minus eighty here, or is minus twenty genuinely enough? – tess_amankwah 7 months ago
add a comment
1

The short version: water enables most of it, oxygen enables oxidation, surfaces enable adsorption, and agitation enables aggregation.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

Nothing here is medical advice, and research-use compounds are not approved for human use.

At dilute concentrations, suspect adsorption before you suspect chemistry.

shareimprove this answerflag
HP
answeredh_pergande71k15824 Apr 2026
5The desiccant point is under-appreciated and costs nothing to act on. – lucia_marchetti 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.